These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 550637)

  • 1. [Clinical trials of new drugs and their registration in Czechoslovakia].
    Elis J; Heinige A
    Zdrav Aktual; 1979; 191():139-43. PubMed ID: 550637
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical and legal aspects of clinical trials of drugs.
    Stolinová J
    Sante Publique (Bucur); 1980; 23(2):115-29. PubMed ID: 7209739
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular drugs in Czechoslovakia--registration and consumption data.
    Seflová M; Sechser T; Strnadová J; Skop B; Váchová M; Svihovec J
    Pol J Pharmacol Pharm; 1989; 41(6):533-7. PubMed ID: 2485903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Registration of industrially manufactured drugs in CSSR].
    Heinige A
    Cesk Farm; 1971 Jan; 20(1):8-9. PubMed ID: 5546601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scandinavian guidelines for clinical trials].
    Westman-Naeser S
    Lakartidningen; 1990 Oct; 87(42):3382-4. PubMed ID: 2233007
    [No Abstract]   [Full Text] [Related]  

  • 6. [New reform of the legal protection of patents in Czechoslovakia].
    Círman Z
    Cesk Farm; 1975 Sep; 24(7):307-12. PubMed ID: 1203997
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled drug trials from the forensic view point. Admissibility criteria of the drug law].
    Eser A
    Internist (Berl); 1982 Apr; 23(4):218-26. PubMed ID: 7045024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sale of proprietary drugs in Czechoslovakia].
    Zdrav Rev Vestn Minist Zdrav; 1950 Aug; 25(8):226. PubMed ID: 14782567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendation of 12 September 1994 regarding the report on serious consequences related to biomedical research on drugs and related products. Agence de Médicaments, Direction de l'Evaluation, Saint Denis, France].
    Therapie; 1995; 50(6):543-6. PubMed ID: 8745954
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protection of patents in pharmacy, chemistry and microbiology in Czechoslovakia].
    Círman Z
    Cesk Farm; 1975 Oct; 24(8):344-50. PubMed ID: 1204002
    [No Abstract]   [Full Text] [Related]  

  • 11. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulations for the control of narcotic drugs in Czechoslovakia.
    Parrak V
    Bull Narc; 1972; 24(3):45-6. PubMed ID: 4486202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Planning for prescribing and distributing foreign drugs].
    Kulhánek M; Partis J
    Zdrav Aktual; 1979; 191():131-8. PubMed ID: 550636
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the new arrangement for extraordinary importation of drug to Czechoslovakia].
    Kulhánek K; Partis J
    Cas Lek Cesk; 1969 May; 108(21):642-4. PubMed ID: 5788082
    [No Abstract]   [Full Text] [Related]  

  • 15. [70 years of drug control in Czechoslovakia].
    Elis J
    Cesk Farm; 1988 Sep; 37(7):289-90. PubMed ID: 3058326
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trials for medicinal products. New European and national legal rules].
    Kreutz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [30 years of drug control in liberated Czechoslovakia].
    Buriánek J
    Cesk Farm; 1975 Nov; 24(9):361-3. PubMed ID: 766983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs and their safety as secured by legal regulations from the aspect of the society at large].
    Kostka V; Solich J
    Cesk Zdrav; 1986 Sep; 34(8-9):360-3. PubMed ID: 3769040
    [No Abstract]   [Full Text] [Related]  

  • 19. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 20. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.